← all works
RETRACTED: A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk – Study rationale and design
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Post-publication record
OpenAlex flags this work as retracted, but it carries no matching Retraction Watch record in this frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Mechanisms of Ageing and Development
- Topic
- Diabetes Treatment and Management
- Field
- Medicine
- Canadian institutions
- Hamilton Health SciencesPopulation Health Research InstituteMcMaster University
- Funders
- National Institutes of HealthAlzheimer's Association
- Keywords
- DementiaMetabolic syndromeCognitionMedicineInsulinDiabetes mellitusDulaglutideCognitive declineGerontologyInternal medicinePsychiatryEndocrinologyType 2 diabetesExenatideDisease
- Has abstract in OpenAlex
- no